Journal Club. Paul Rosenfeld and coworkers at the University of Toronto recently reported in the journal Viruses that Rocaglamide, a structurally novel natural product, inhibits HIV-1 […]
Drug Approval News: Johnson & Johnson (J&J) has received approvals from both the European Commission (EC) and US Food and Drug Administration (FDA) for its tuberculosis […]
The Focus Biomolecules Website is set to allow the use of cookies. Cookies help us to give you the best experience on our website. By clicking Accept or continuing to use the site, you agree to use our cookies. If you decline we will not track your information but your browsing experience might be limited. For more information on our Privacy Policy click here.
